This paper investigates the effector mechanisms of immune clearance in the lungs of rats immunized against mucoid Pseudomonas aeruginosa. After the gut-associated lymphoid tissue was primed and after a subsequent pulmonary challenge with live bacteria, significantly accelerated bacterial clearances from the lung and raised levels of anti-P. aeruginosa antibodies in sera (immunoglobulin G [IgG], IgA, and IgM) and bronchoalveolar lavages (IgG and IgA) were observed for all immune animals. These changes were associated with enhanced recruitment, chemotaxis, chemokinesis, phagocytic indices, and chemiluminescence of pulmonary polymorphonuclear neutrophils (PMN). In the alveolar spaces of immune animals, an increase in the level of PMN recruitment was not associated with higher levels of leukotriene B4 (LTB4). In contrast, in nonimmune animals that were intratracheally infected with P. aeruginosa, the levels of recruitment and activity of alveolar PMN were lower than those in immune rats but PMN infiltration correlated with a significant increase in the synthesis of LTBI4 in the alveolar space. In pulmonary tissue, LTB4 synthesis for both groups was elevated. These findings suggest that accelerated clearance of mucoid P. aeruginosa from the lungs of intestinally immunized rats is due at least in part to factors that induce the enhancement of PMN recruitment and activity in the alveolar space. The mediators that regulate this enhanced response remain unknown but do not seem to include LTB4. The high levels of LTB4 measured in the bronchoalveolar lavages and pulmonary tissues from nonimmune animals infected with live bacteria implicate LTB4 as an important amplifier of the inflammatory response during acute pulmonary infections with mucoid P. aeruginosa in unimmunized hosts.
Pseudomonas aeruginosa is an extracellular opportunistic pathogen which causes fatal infections in compromised individuals such as burn victims and patients with cystic fibrosis (CF) (15, 36) . In CF patients, colonization with P. aeruginosa transits from a nonmucoid to a mucoid form and eventually leads to severe pulmonary disease and death (26) . Because of the poor prognosis of pulmonary colonization with P. aeruginosa in CF patients, a number of investigators have undertaken to assess the prophylactic value of a P. aeruginosa vaccine in an attempt to prevent the initial establishment of the pathogen (2, 13, 23, 32, 34, 35, 38) . However, protection with a vaccine against pulmonary colonization by P. aeruginosa in humans has not yet been achieved. Our laboratory has developed a rat model in which intestinal immunization with killed mucoid P. aeruginosa cells promotes an increase in bacterial clearance from the lung and enhanced survival following a subsequent pulmonary challenge with live bacteria (2) ; however, the mechanisms providing anti-P. aeruginosa protection remained undefined. Colonization with P. aeruginosa induces a strong humoral immune response both in serum and in salivary and pulmonary secretions. These antibodies are elicited against a variety of P. aeruginosa antigens (5, 6, 19, 21, 22, 33, 43) , but they are unable to stop the spread of the bacterium in the lung (4, 8, 10) . In keeping with these findings, production of P. aeruginosa-specific antibodies does not correlate with accelerated bacterial clearance from the lungs in intestinally immunized rats (2) . Clearly, other effector mechanisms of immunity are involved in the host defense against P. aeruginosa, and cell-mediated immunity may play a major role in this protection (24, 34, 44, 46) . In an attempt to further define the effector mechanisms of pulmonary immunity to P. aeruginosa, the aim of the present study was to determine whether the acceleration in bacterial clearance from the lung induced by intestinal immunization was associated with enhancement of recruitment, function, and activity of polymorphonuclear neutrophils (PMN). The results indicate that (i) priming of the gut-associated lymphoid tissue with mucoid P. aeruginosa results in enhanced recruitment, chemotaxis, chemokinesis, and phagocytic activity of PMN following a challenge infection, (ii) these changes correlate with enhanced bacterial clearance from the lung, and (iii) leukotriene B4 (LTB4) synthesis does not appear to be associated with the increased PMN recruitment in the alveolar spaces of immunized rats.
MATERIALS AND METHODS
Animal model. Male, specific-pathogen-free DA were used in all experiments as described previously (2) . All animals were maintained in a specific-pathogen-free environment until the start of the experimental protocol. The rats were fed commercial rodent pellets and given water ad libitum. Mainte- Peroxidase-conjugated goat anti-rat IgA, IgG, and IgM (Nordic) were bound to the antibody-antigen complexes in individual wells, and 3,3',5,5'-tetramethylbenzidine substrate (Sigma, Bioscientific Ltd., Sydney, Australia) was added. A492 was read on a Titertek Multiskan photometer against a standard curve obtained from hyperimmune rat serum. The results were expressed in ELISA units per milliliter of sample, as described previously (47) .
PMN counts and phagocytic indices. Fresh 100-,ul samples of each bronchoalveolar lavage were spun for 10 min at 20 x g onto a microscope slide with a cytospin (Shandon Inc., Pittsburgh, Pa.), and cytocentrifuged specimens were fixed and stained in Diff Quick (Vet. Med. Surg. Suppl. Pty. Ltd., Maryville, Australia). The percentages of alveolar PMN were calculated from three differential counts on each slide. The slides were washed to remove free extracellular bacteria not associated with phagocytes, and the preparations were further evaluated under light microscopy for the determination of two phagocytic indices, i.e., (i) the percentage of PMN that phagocytosed 1 to 5 bacteria and (ii) the percentage of PMN that phagocytosed >5 bacteria.
PMN purification. The bronchoalveolar lavages were centrifuged for 10 min at 250 x g and 5°C. The supernatant was frozen and stored at -70°C until further study. The and 3.0-,m-pore-size membrane filters (type SS; Millipore Corp., Bedford, Mass.). Samples (100 ,ul each) from the cell preparation were placed on the filters in the upper wells of each of five chambers set up in one of the following manners: (i) bottom and top of chamber filled with HBSS for calculation of random migration; (ii) bottom of chamber filled with casein (2.5 mg of HBSS per ml) and top of chamber filled with HBSS, for nonspecific chemotaxis; (iii) bottom of chamber filled with 108 live homologous P. aenuginosa cells per ml in HBSS and top of chamber filled with HBSS, for specific chemotaxis; (iv) bottom and top of chamber filled with 5% immune serum in HBSS for chemokinesis; and (v) as above, but with 5% serum from nonimmune rats. After incubation for 60 min at 37°C in an atmosphere containing 5% CO2, the membrane filters were removed, fixed in absolute alcohol, stained with Harris hematoxylin, washed in distilled water, dehydrated in ethanol, stored overnight in xylene, and mounted between slide and coverslip. The leading fronts of migrating PMN were measured under light microscopy as described previously (52 
RESULTS
Bacterial clearance and PMN counts. As illustrated in Table 1 , IPP immunization with killed bacteria resulted in significantly enhanced bacterial clearance from the lung following a subsequent pulmonary challenge with live P. aeruginosa. After 0.5 h of challenge, immunized animals showed a reduction in the numbers of bacteria recovered from their bronchoalveolar lavages of 66%, compared with nonimmune rats. After 4 h, the immunized rats had cleared 97% of the bacteria. After 4 h of challenge, the enhanced clearance rate in immune animals was associated with an increase of more than 25-fold in the number of bronchoalveolar PMN over that in nonimmune challenged rats. PMN represent a small portion of the bronchoalveolar cell population in normal rat lungs (1.9% + 1.0%) and in the lungs of immune but unchallenged animals (2.3% ± 1.1%). Live bacterial challenge in nonimmune rats induced PMN to become the bulk of the alveolar cell population (0.5 h, 3.1% ± 0.4%; 4 h, 65.1% ± 2.2%), and the proportion of PMN in rats that had been previously immunized was significantly higher (0.5 h, 10.1% ± 1.2%; 4 h, 93.3% t 1.2%) ( Table 1) .
Anti-P. aeruginosa antibodies. The results from the anti-P. aenrginosa IgA, IgG, and IgM antibody assays are illustrated in Fig. 1 . IPP immunization with P. aeruginosa induced a strong antibody response both in the sera (IgA, IgG, and IgM) and in the bronchoalveolar secretions (IgA and IgG). In both cases, IgA was the most significantly increased isotype. The increase in bronchoalveolar IgM from immune animals failed to reach significance (P = 0.079 compared with that in nonimmune animals).
Phagocytic indices. Light microscopy evaluation of cytospin preparations allowed easy identification of PMN that had phagocytosed bacteria (Fig. 2) . Intracellular localization of the phagocytosed bacteria was confirmed with transmission electron microscopy (Fig. 2) . After both 0.5 and 4 h of challenge, pulmonary PMN that had phagocytosed more than five bacteria were found in significantly greater concentrations in the lavages from immune rats than in those of nonimmune animals, whereas the percentages of PMN that had phagocytosed one to five bacteria were not significantly different between both groups (Fig. 3) .
Chemiluminescence. In all experiments, PMN populations isolated on Percoll were >95% viable and >98% pure. The results from the PMN chemiluminescence measurements are illustrated in Fig. 4 (Fig. 4) . Table 2 . Compared with PMN from nonimmune rats, PMN from immune animals exhibited significantly (P < 0.05) enhanced chemotaxis for casein and, even more significantly (P < 0.005), enhanced chemotaxis for live P. aeruginosa. Chemokinesis in the presence of either type of serum was significantly (P < 0.005) increased in PMN from immune rats. No significant difference between the PMN random migration rates of both groups was observed.
LTB4 synthesis. Levels of LTB4 in serum samples, bronchoalveolar lavages, and lung homogenates are illustrated in Fig. 5 . After 0.5 h of challenge, LTB4 levels between both groups were not different in any of the areas studied. After 4 h, no difference had appeared in the serum samples. However, at 4 h, the LTB4 content in bronchoalveolar lavages from nonimmune rats was increased 20-fold over values from immune or control animals, which were not different. Also at 4 h, LTB4 levels in lung homogenates of both the nonimmune and the immune groups were significantly (P < 0.05) increased over those in controls.
DISCUSSION
This study correlates enhancement of pulmonary PMN recruitment, activity, and function with acceleration of P. aeruginosa clearance from the lungs of rats intestinally immunized with killed bacteria. Priming of the gut-associated lymphoid tissue with killed mucoid P. aeruginosa cells induced protection against live pulmonary challenge with the homologous strain. After pulmonary challenge with live P. aeruginosa cells, compared with phagocytes from nonimmune sham-treated rats, bronchoalveolar PMN from immunized animals were found in significantly greater numbers and had phagocytosed more bacteria. These changes were associated with increased bacterial clearance and enhanced PMN chemiluminescence, chemokinesis, and specific chemotaxis but not with increased levels of LTB4 in the bronchoalveolar lavages. The results indicate that IPP immunization, which mimics intestinal immunization (7, 18) , can favorably alter the course of a P. aeruginosa infection in the lung and that accelerated recruitment and increased activation of bronchoalveolar PMN are important effector mechanisms of protective immunity in the present model. Enhanced LTB4 synthesis in the alveolar space does not appear to be implicated in this response.
Consistent with the hypothesis that cellular effector mechanisms play a central role in the protection of the immune lung, subsequent pulmonary challenge in mice immunized with Listena monocytogenes is controlled by an influx of activated macrophages (46) . In addition, experiments performed in this laboratory with an animal model similar to the one described here identified PMN activation as an effector mechanism of protective immunity against nontypeable Haemophilus influenzae after priming of the gut-associated lymphoid tissue (47) . In addition, studies of mice immunized against P. aeruginosa with a mixture of vinblastine sulfate and a P. aeruginosa polysaccharide have shown that this microorganism could be directly killed by T lymphocytes after an intraperitoneal challenge (24, 34 The results from the phagocytic-index studies revealed an increase in the percentage of PMN that had phagocytosed >5 bacteria in immune animals. In contrast, the concentrations of PMN that had phagocytosed one to five bacteria were not different between the PMN populations of immune and nonimmune animals, suggesting that immunization had enhanced the phagocytic activity of individual PMN. Moreover, PMN from immune animals exhibited a more significantly increased chemotaxis for live P. aeruginosa (P < 0.005) than for casein (P < 0.05), compared with PMN from nonimmune rats. Further experiments will allow a determination of whether the findings presented here reflect a specific enhancement of the PMN immune response to P. aeruginosa or whether immunization increases PMN sensitivity to P. aeruginosa chemotaxins, which seem to be active even in the absence of host humoral factors (11) .
The protective role of pulmonary PMN against a primary P. aeruginosa infection has been well documented. In immunosuppressed guinea pigs, increased mortality following a pulmonary challenge with P. aeruginosa correlated with a diminished PMN response in the lung (31) . In another study, granulocyte transfusion therapy favorably altered the course of experimental P. aeruginosa pneumonia in leukopenic dogs (3). More recently, unsuccessful pulmonary clearance of the microorganism in young mice has been associated with a transient, age-dependent reduction in PMN activity (42) . Hence, in addition to the obvious significance of the role played by PMN in controlling primary infections with P. aeruginosa, the present study now shows that PMN activation is a central effector mechanism of pulmonary immunity following gut-associated lymphoid tissue priming. In addition, since IPP immunization in this model provides protection in the lung, these findings further support the concept of a common mucosal system (27) . Finally, since it appears that mucoid and nonmucoid P. aeruginosa variants are equally sensitive to killing by a 55-kDa bactericidal protein from human PMN (41), the results may identify enhanced pulmonary PMN function as a possible therapeutic target for the development of an effective anti-P. aeruginosa pneumonia vaccine. However, because PMN have also been implicated in the propagation of lung injury in patients with CF (28) as well as in damage to other mucosal systems (49, 50) , possible detrimental side effects due to immunization-induced PMN activation must be carefully investigated.
The apparent efficacy of the role played by PMN in controlling primary and secondary pulmonary infections with P. aeruginosa may seem surprising in light of the numerous immunosuppressive activities displayed by this microorganism. Indeed, it has been established that P. aeruginosa may impair opsonic phagocytosis via the proteolysis of IgG and C3b opsonic molecules (9, 10, 39, 45) , via the barrier effect of alginate preventing antibody and/or complement binding (25, 26) , and/or via the breakdown of opsonic fibronectin (51) . In addition, leucocidin, exotoxin A, hemolysin, and a 65-kDa PMN inhibitor, all released by P. aeruginosa, as well as the inactivation of interleukin-2, (16, 20, 29, 30, 37) . Yet in the present study, after 0.5 h of challenge, immune animals already displayed a significantly increased recruitment of bronchoalveolar PMN over that with nonimmune animals, while immunization alone, i.e., which was not followed by a pulmonary challenge, had no effect on PMN recruitment into the lungs. As PMN recruitment, function, and activity increased, the rate of bacterial clearance was gradually accelerated in immune animals. In addition, the calculated ratio of the number of cleared bacteria to alveolar PMN in immune animals (-8:1) fits well within the physiological range of the numbers of phagocytosed bacteria counted in PMN from immune animals (1 to >20 [ Fig. 2 (17, 40, 48, 50) . Studies of the generation of eicosanoids in human blood after the phagocytosis of zymosan showed that LTB4 synthesis increased to maximum levels from 30 to 60 min after the stimulus and remained essentially constant thereafter for at least another hour (12) . Also, increased LTB4 release by PMN parallels the kinetics of opsonic phagocytosis of H. influenzae in vitro (14) . Finally, in an animal model of colonic inflammation, increased LTB4 synthesis correlated with PMN infiltration for a duration of several weeks (50) . In keeping with these observations, the present study showed that PMN infiltration was associated with markedly increased LTB4 synthesis in the bronchoalveolar spaces and pulmonary tissues of nonimmune rats acutely challenged with mucoid P. aeruginosa. In contrast, the data clearly demonstrate that LTB4 production does not explain the enhanced PMN recruitment and subsequent clearance in rats previously immunized with mucoid P. aeruginosa. In conclusion, these findings implicate LTB4 as an important amplifier of the inflammatory response during a primary pulmonary infection with mucoid P. aeruginosa; however, following immunization and subsequent live pulmonary challenge with this microorganism, accelerated PMN infiltration into the alveolar space is not LTB4 dependent. The mechanisms circumventing LTB4 synthesis (or, alternatively, inactivating free LTB4) in this model need to be clarified, but this observation alone represents a promising finding in light of the detrimental effects of LTB4 in a number of mucosal diseases. We are currently investigating whether enhanced interleukin-1 production may explain LTB4-independent PMN 
